FDA Approves Eylea (aflibercept) Injection Prefilled Syringe

21:08 EDT 12 Aug 2019 |

TARRYTOWN, N.Y., Aug. 13, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Chemistry, Manufacturing and Controls (CMC) Prior-Approval Supplement...

Original Article: FDA Approves Eylea (aflibercept) Injection Prefilled Syringe


More From BioPortfolio on "FDA Approves Eylea (aflibercept) Injection Prefilled Syringe"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...